Clinical trials
Phase 2 Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
206 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 5 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 8 |
| 2006 | 14 |
| 2007 | 15 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 9 |
| 2011 | 16 |
| 2012 | 12 |
| 2013 | 14 |
| 2014 | 9 |
| 2015 | 10 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 6 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 139 |
| Unknown status | 29 |
| Recruiting | 12 |
| Terminated | 12 |
| Not yet recruiting | 6 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 12 |
| Cordis US Corp. | 5 |
| Amaranth Medical Inc. | 4 |
| Eli Lilly and Company | 4 |
| Resverlogix Corp | 4 |
| AstraZeneca | 3 |
| Gilead Sciences | 3 |
| Hospital TotalCor | 3 |
| Indiana University | 3 |
| Johns Hopkins University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 206 |
| Atherosclerosis | 23 |
| Myocardial Ischemia | 23 |
| Coronary Disease | 21 |
| Cardiovascular Diseases | 20 |
| Heart Diseases | 18 |
| Myocardial Infarction | 17 |
| Inflammation | 11 |
| Angina Pectoris | 9 |
| Angina, Stable | 9 |
Trials
Showing 51 to 75 of 206. Each trial links to its page on Pharma Observatory.
106 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.